Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae) (DRECOREST2)

Helsinki University Central Hospital (HUCH)

Status: Completed

Conditions: Restenosis, Vascular Graft; Vascular Access Complication; Dialysis Related Complications

Treatments: Device: Conventional angioplasty; Device: Angioplasty with drug-eluting balloon

Study type: Interventional

Funder types: Other

Identifiers

NCT03036241

DRECOREST2 - 23rd Jan 2013

Details and patient eligibility

About

The purpose of this study is to determine whether the use of drug-eluting balloons is effective in the treatment of (re)stenosis in dialysis fistulae.

Full description

Drug-eluting devices have proved beneficial in the treatment of stenosis in native coronary and lower limb arteries. Stenosis and restenosis is a known problem in dialysis fistulae and drug-eluting devices might be beneficial in this field as well.

In the procedure a conventional balloon is passed through the stenosis which is then dilated. After this patients are randomized before a second dilatation with either a conventional balloon or a drug-coated balloon.

The stenosis is evaluated preoperatively and followed up by means of ultrasound by a vascular technician. Follow-up will end at 12 months.

Enrollment: 39 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any dialysis access w/ native vessels warranting intervention

Exclusion criteria

• Previous PTA with drug-eluting balloon, thrombolysis, coagulopathy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

39 participants in 2 patient groups

Drug-eluting balloon

Experimental group

Treatment:

Device: Angioplasty with drug-eluting balloon

Conventional angioplasty

Active Comparator group

Treatment:

Device: Conventional angioplasty